[1] Nascimento-Carvalho CM.Community-acquired pneumonia among children:The latest evidence for an updated management[J].J Pediatr (Rio J),2020,96(Suppl 1):29-38.
[2] de Benedictis FM,Kerem E,Chang AB,et al. Complicated pneumonia in children[J].Lancet,2020,396(10253):786-798.
[3] 中华人民共和国国家健康委员会,国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志,2019,12(1):6-13.
[4] 国家卫生健康委员会人才交流服务中心儿科呼吸内镜诊疗技术项目专家组,中国医师协会儿科医师分会内镜专业委员会,中国医师协会内镜医师分会儿科呼吸内镜专业委员会,等.中国儿童难治性肺炎呼吸内镜介入诊疗专家共识[J]. 中国实用儿科杂志,2019,34(6):449-457.
[5] 左安霞,华芸,仲苏蕾,等.扬州地区2 649例儿童肺炎病例病原菌分布特征及耐药性分析[J].华南预防医学,2022,48(12):1500-1503.
[6] 温晓峥,苏惠婷,崔亚利. 2014—2019年我院儿童患者临床分离病原菌分布及耐药性分析[J]. 中国药房,2020,31(6):724-729.
[7] 李英,汪奇伟,商亚敏,等. 儿童社区获得性肺炎病原菌及其疗效的影响因素[J].中华医院感染学杂志,2023,33(3):471-475.
[8] House DR,Rijal S,Adhikari S,et al.Prospective evaluation of World Health Organization guidelines for diagnosis of pneumonia in children presenting to an emergency department in a resource-limited setting[J].Paediatr Int Child H,2020,40(4):1-4.
[9] 秦晓柳,饶文絮,孙锋,等.2019—2021年安康市儿童肺炎病原菌分布及室内环境危险因素[J].公共卫生与预防医学,2022,33(5):95-99.
[10] Tsai TA,Tsai CK,Kuo KC,et al.Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children[J].J Microbiol Immunol Infect,2021,54(4):557-565.
[11] 黄小燕,东建亭,曾宪鍫.儿童社区获得性肺炎病例病原谱分析[J].分子诊断与治疗杂志,2023,15(1):14-17.
[12] Kutty PK,Jain S,Taylor TH,et al.Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia[J].Clin Infect Dis,2019,68(1):5-12.
[13] 蔡忠忠,徐震,薛鑫. 不同地区儿童社区获得性肺炎常见革兰阴性菌对碳青霉烯类药物的耐药性差异及变迁[J].中国现代医生,2023,61(18):87-90.
[14] 谢强,徐添天,谢瑞玉,等.碳青霉烯类耐药肺炎克雷伯菌毒力基因型及分子流行病学研究[J].热带医学杂志,2023,23(3):327-330,280.
[15] 涂海健,黄亚雨,陈淑娟,等.携带NDM-1基因合并膜孔蛋白OmpK36缺失肺炎克雷伯菌耐药性分析[J].分子诊断与治疗杂志,2020,12(1):49-54,63.
[16] Mobasseri G,Thong KL,Teh CSJ.Genomic analysis revealing the resistance mechanisms of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from pig and humans in Malaysia[J]. Int Microbiol,2021,24(2):243-250.
[17] 麦文慧,卓珠琳,郑青,等.海口市儿童急性下呼吸道细菌感染的病原学特征及耐药性分析[J].中国热带医学,2021,21(9):833-838.
[18] Tanaka E,Wajima T,Uchiya KI,et al.Quinolone resistance is transferred horizontally via uptake signal sequence recognition in Haemophilus influenzae[J].Antimicrob Agents Chemother,2022,66(2):e0196721.
[19] 鲍燕敏,郑跃杰,杨永弘. 《中国儿童肺炎链球菌性疾病诊断、治疗和预防专家共识》解读[J]. 中华实用儿科临床杂志,2021,36(21):1601-1604.
[20] 黄李丹,杨美娟,孙爱华,等. 肺炎链球菌耐药分子机制的研究进展[J]. 中南医学科学杂志,2021,49(3):275-280.
[21] Sharma S,Rao R,Reeve SM,et al.Azaindole based potentiator of antibiotics against gram-negative bacteria[J].ACS Infect Dis,2021,7(11):3009-3024.
[22] 曾建业,陈丹丹,王俣棋,等. 金黄色葡萄球菌生物被膜耐药机制研究进展[J]. 中国感染控制杂志,2023,22(2):244-248.
[23] 蓝锴,钟国升,刘宇阳,等.MRSA对万古霉素和替考拉宁的异质性耐药情况及分子分型[J].分子诊断与治疗杂志,2021,13(11):1770-1774,1778.
[24] Broad J,Le Doare K,Heath PT,et al.The current state of immunization against Gram-negative bacteria in children:A review of the literature[J].Curr Opin Infect Dis,2020,33(6):517-529. |
